Expert Blog

How to Assess Second-Line Diabetes Agents for Patients at Risk for Major Osteoporotic Fractures

Doron Schneider, MD, FACP
General Internist
Photo of Ann Schwartz PhD at UCSF
Ann Schwartz, PhD, MPH
Professor, UCSF School of Medicine

What are the best ways to help prevent your type 2 diabetes patient avoid major osteoporotic fractures many diabetes medications can actually increase the risk of fracture?

Doron Schneider, MD and Ann Schwartz, PhD walk you through a  case case study that includes an exploration of current science, clinical recommendations and medication options. The case study provides insights into mitigating fracture risk while effectively treating type 2 diabetes.